Browsing by Subject "ickle cell disease; hydroxyurea; congenital anomalies; pregnancy JBI Database System Rev Implement Rep 2018; 16(5):1135–1140."
Now showing items 1-1 of 1
-
Prevalence and incidence of congenital anomalies amongst babies born to women with sickle cell disease and exposed to hydroxyurea during pregnancy: a systematic review protocol
(2018)What is the prevalence and incidence of congenital anomalies among babies born to women with sickle cell disease (SCD) and who have been exposed to hydroxyurea (HU) therapy at any time in their pregnancy? The objective ...